baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BVT Put 130 NVO 17.01.2025/ DE000VM9CS03 /

2024-08-09 8:25:00 AM	Chg.-0.46	Bid9:59:57 PM	Ask9:59:57 PM	Underlying	Strike price	Expiration date	Option type
1.08EUR	-29.87%	- Bid Size: -	- Ask Size: -	Novo Nordisk	130.00 USD	2025-01-17	Put

TeleTrader 08-07 Europe higher premarket amid earnings reports

TeleTrader 07-05 Novo Nordisk slammed over undisclosed payments

GlobeNewswire 07-02 Notified Celebrates Winners of 2024 IR Magazine European Awards

GlobeNewswire 06-28 SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteri...

GlobeNewswire 06-27 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

GlobeNewswire 06-24 Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American ...

GlobeNewswire 06-18 Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesit...

GlobeNewswire 06-18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...

GlobeNewswire 06-17 Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Share...

TeleTrader 06-15 Novo Nordisk CEO to voluntarily testify before US committee

GlobeNewswire 06-14 Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs

GlobeNewswire 06-13 Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Chil...

GlobeNewswire 06-13 Biosplice Announces Collaboration with Novo Nordisk in Diabetes

GlobeNewswire 06-11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...

GlobeNewswire 06-10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

GlobeNewswire 06-10 Veru to Present at the American Diabetes Association's 84th Scientific Sessions

GlobeNewswire 06-03 Aeterna Zentaris and Ceapro Complete Merger Transaction

GlobeNewswire 05-31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...

GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More

GlobeNewswire 05-22 Veru to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 05-15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...

GlobeNewswire 05-15 Aeterna Zentaris Reports First Quarter 2024 Financial Results

GlobeNewswire 05-14 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...

GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...

BVT Put 130 NVO 17.01.2025/ DE000VM9CS03 /

If you wish to receive reply to your feedback, please provide your email address.